USA: +1 347 690-0211 | UK: +44 2032 894158 | JAPAN: +81 50 5806 9039 | Translate : 

report img

Cardiac Rhythm Management Devices Market Size, Share, Growth Analysis Report By Product (Electrocardiogram (ECG) Devices, Implantable Loop Recorders (ILR), Cardiac Output Monitoring (COM) Devices, Event Monitors, Pacemakers, Cardiac Resynchronization Therapy (CRT) Devices, Defibrillator, External Defibrillator, Ventricular Assist Devices (VADs)), By End-User (Hospitals & Clinics, Home Settings, Ambulatory Surgical Centers (ASCs)), and By Region - Global and Regional Industry Insights, Overview, Comprehensive Analysis, Trends, Statistical Research, Market Intelligence, Historical Data and Forecast 2022 – 2028

Covid-19

Global Cardiac Rhythm Management Devices Market Size, Share

The pandemic continues to cause unprecedented disruption across industries worldwide.Get detailed insights regarding the impact of COVID-19 on the market. Request Sample

Industry Insights

[229+ Pages Report] According to Facts and Factors, the Global Cardiac Rhythm Management Devices Market size was valued at USD 17,274.6 million in 2021 and is predicted to increase at a CAGR of 6.3% to USD 24,071.19 million by 2028. The study examines the market in terms of revenue in each of the major regions, which are classified into countries. The report analyses the global cardiac rhythm management devices market’s drivers and restraints, as well as the impact they have on-demand throughout the projection period. In addition, the report examines global opportunities in the cardiac rhythm management devices market.

logoMarket Overview

Cardiac rhythm management devices help patients with heart rate and rhythm problems maintain normal cardiac rhythm. These devices are critical in the treatment of major cardiac illnesses such as heart failure, atrial fibrillation, atrial flutter, signs of a recent heart attack, coronary ischemia, lack of oxygen delivery to cardiac muscles, pharmacological effects, and specific genetic mistakes, among others. Factors driving the market include an increase in the frequency of cardiac illnesses, technological improvements, patient awareness, and an increase in the number of unmet medical requirements in developing and underdeveloped countries.

The development of novel MRI-labeled devices, as well as growth possibilities in Asia-Pacific and LAMEA emerging economies, are likely to create opportunities for growth in the cardiac monitoring and heart rhythm management market over the projection period. Elderly people confront a variety of cardiac issues, which can lead to heart failure, increasing the demand for pacemakers, ventricular assist devices (VADs), electrocardiograms (ECGs), and implanted cardioverter defibrillators (ICDs) (ICDs). As a result, this aspect has a significant impact on the growth of the CM and CRM devices market.

logo Growth Drivers

The increasing adoption of novel technologies, as the market is heavily influenced by technical innovation in this sector. Furthermore, a surge in heart illnesses is expected to raise the demand for effective treatment alternatives. As a result, during the forecast period, this factor is likely to have a substantial impact on the growth of the CM and CRM devices market.

However, therapeutic radiation used in cancer treatment can have an impact on a patient's ability to use implantable cardiac rhythm devices. The implanted device technology employs complementary metal-oxide-semiconductor (CMOS) chips, which are susceptible to damage from therapeutic levels of radiation, however, this varies depending on the type of device used. This is one of the most important constraints limiting the use of cardiac rhythm management devices, as the implants are highly sensitive and malfunctioning might have significant repercussions. On the other side, the exorbitant cost of these devices, along with limited insurance coverage, is limiting market expansion.

logo COVID – 19 Impact

The COVID-19 pandemic has had an influence on numerous businesses, including the cardiac rhythm management (CRM) device market. Due to the postponement of cardiovascular treatments, market participants have suffered significant losses in their cardiac rhythm management segments. The drop was most noticeable in the ICD, CRT-D, and pacemaker segments.  

However, the COVID outbreak has increased the preference for remote monitoring of individuals with cardiovascular problems. This change was made in order to limit the risk of infection caused by the frequent hospital and clinic visits. Several firms have introduced services for remote cardiac patient monitoring. Several start-ups have also launched products that can be used to monitor cardiovascular patients.

logoSegmentation Analysis

The Global Cardiac Rhythm Management Devices Market is segregated based on Product, and End User.

In terms of Product, over the projection period, the cardiac resynchronization therapy (CRT) segment is predicted to increase at a rapid pace. This segment is driven by associated benefits such as reduced blood transfusion, infection risk, and hospital stay. To reduce bradycardia and cardiac arrest, doctors are increasingly advocating minimally invasive operations for CRT-Pacemaker implantation. The preference for minimally invasive CRT-P implantation techniques is likely to improve sales during the forecast period.

In terms of End Users, hospitals accounted for the largest share of the cardiac monitoring and heart rhythm management equipment market. The growing prevalence of CVD, the growing number of patient visits to hospitals for diagnosis, the growing number of cardiac implant procedures, and the availability of funding for these therapies in developed markets all contribute to the size of this category.

logoReport Scope

Report Attribute

Details

Market Size in 2021

USD 17,274.6 Million

Projected Market Size in 2028

USD 24,071.19 Million

CAGR Growth Rate

6.3% CAGR

Base Year

2021

Forecast Years

2022-2028

Key Market Players

Abiomed, Inc., Berlin Heart GmbH, Biotronik SE & Co. KG, Bosten Scientific Corporation, Cardic Science Corporation, General Electric Company (GE), Hill-Rom Holdings, Inc., Jarvik Heart,Inc., Koninklijke Philips N.V., LivaNova PLC, Medtronic plc, Nihon Kohden Corporation, ReliantHeart Inc., SCHILLER AG, St. Jude Medical, Inc., and Others

Key Segment

By Product, End-User, and Region

Major Regions Covered

North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa

Purchase Options

Request customized purchase options to meet your research needs. Explore purchase options

logoRegional Landscape

North America is predicted to dominate the cardiac rhythm management devices market during the forecast period. Higher adoption of pacemakers and ICD implants is likely to drive the market in North America, owing to a steady shift in patient preference toward preventative care and the increasing prevalence of cardiac diseases. Furthermore, rigorous government rules regarding the installation of external defibrillators in public locations are expected to result in higher use of external defibrillators, which would eventually enhance the market.

The market for cardiac rhythm management devices in the Asia Pacific is expected to grow at the fastest rate during the forecast period, owing to rising R&D investments by international players. In addition, rising R&D investments by international players in response to rising government healthcare expenditure, rising prevalence of cardiac disorders, and rising per capita income in South Asian countries, are driving the growth of the market. In the Asia Pacific, rising awareness of these CRM devices is expected to boost the adoption of cardiac management devices, accelerating the market in the region.

logoCompetitive Landscape

The report contains qualitative and quantitative research on the global Cardiac Rhythm Management Devices Market, as well as detailed insights and development strategies employed by the leading competitors. The report also provides an in-depth analysis of the market's main competitors, as well as information on their competitiveness. The research also identifies and analyses important business strategies used by these main market players, such as mergers and acquisitions (M&A), affiliations, collaborations, and contracts. The study examines, among other things, each company's global presence, competitors, service offers, and standards.

List of Key Players in the Global Cardiac Rhythm Management Devices Market:

  • Abiomed, Inc.
  • Berlin Heart GmbH
  • Biotronik SE & Co. KG
  • Bosten Scientific Corporation
  • Cardic Science Corporation
  • General Electric Company (GE)
  • Hill-Rom Holdings, Inc.
  • Jarvik Heart,Inc.
  • Koninklijke Philips N.V.
  • LivaNova PLC
  • Medtronic plc
  • Nihon Kohden Corporation
  • ReliantHeart Inc.
  • SCHILLER AG
  • St. Jude Medical, Inc.

The global cardiac rhythm management devices market is segmented as follows:

logoBy Product

  • Electrocardiogram (ECG) Devices
  • Implantable Loop Recorders (ILR)
  • Cardiac Output Monitoring (COM) Devices
  • Event Monitors
  • Pacemakers
  • Cardiac Resynchronization Therapy (CRT) Devices
  • Defibrillator
  • External Defibrillator
  • Ventricular Assist Devices (VADs)

logoBy End-User

  • Hospitals & Clinics
  • Home Settings
  • Ambulatory Surgical Centers (ASCs)

logoBy Region

  • North America
    • The U.S.
    • Canada
    • Mexico
  • Europe
    • France
    • The UK
    • Spain
    • Germany
    • Italy
    • Nordic Countries
      • Denmark
      • Sweden
      • Norway
    • Benelux Union
      • Belgium
      • The Netherlands
      • Luxembourg
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • Australia
    • South Korea
    • Southeast Asia
      • Indonesia
      • Thailand
      • Malaysia
      • Singapore
      • Rest of Southeast Asia
    • Rest of Asia Pacific
  • The Middle East & Africa
    • Saudi Arabia
    • UAE
    • Egypt
    • South Africa
    • Rest of the Middle East & Africa
  • Latin America
    • Brazil
    • Argentina
    • Rest of Latin America

Covid-19

Cardiac Rhythm Management Devices Market

The pandemic continues to cause unprecedented disruption across industries worldwide.Get detailed insights regarding the impact of COVID-19 on the market. Request Sample

Industry Major Market Players

  • Abiomed Inc. 
  • Berlin Heart GmbH 
  • Biotronik SE & Co. KG 
  • Bosten Scientific Corporation 
  • Cardic Science Corporation 
  • General Electric Company (GE) 
  • Hill-Rom Holdings Inc. 
  • Jarvik Heart Inc. 
  • Koninklijke Philips N.V. 
  • LivaNova PLC 
  • Medtronic plc 
  • Nihon Kohden Corporation 
  • ReliantHeart Inc. 
  • SCHILLER AG 
  • St. Jude Medical Inc.

Frequently Asked Questions

The global cardiac rhythm management devices market is segmented on the basis of product, end user, and region.
Some of the key factors driving the global cardiac rhythm management devices market growth includes increasing adoption of novel technologies, and surge in heart illnesses.
The key growth strategies of cardiac rhythm management devices market players include product portfolio expansion, mergers & acquisitions, agreements, geographical expansion, and collaborations.
North America is expected to witness maximum growth for global cardiac rhythm management devices market during forecast period.
Some of the major companies operating in the global cardiac rhythm management devices market are Abiomed, Inc., Berlin Heart GmbH, Biotronik SE & Co. KG, Bosten Scientific Corporation, Cardic Science Corporation, General Electric Company (GE), Hill-Rom Holdings, Inc., Jarvik Heart,Inc., Koninklijke Philips N.V., LivaNova PLC, Medtronic plc, Nihon Kohden Corporation, ReliantHeart Inc., SCHILLER AG, St. Jude Medical, Inc., and among others.
why choose fnf
key questions answers

Related Reports

report img

Electroencephalography Equipment Market Report 2022 – 2028

[227+ Pages Report] According to Facts and Factors, the global electroencephalography equipment market was valued at USD 1528.5 million in 2021 and is predicted to increase at a CAGR of 4.1% to USD 1945.2 million by 2028. The study examines the market in terms of revenue in each of the major regio...

Published Date : 15-Jun-2022 | | Category : | Pages : 227 | Format : Read more

Inquiry for Buying Request Sample
report img

Menstrual Cups Market Report , 2021 – 2026

According to the report published by the Facts Factors, global demand for the menstrual cups market was estimated at approximately USD 720.6 Million in 2020 and is expected to generate revenue of around USD 980.4 Million by the end of 2026, growing at a CAGR of around 5.5% between 2021 and 2026. ...

Published Date : 29-Dec-2021 | | Category : | Pages : 171 | Format : Read more

Inquiry for Buying Request Sample